Literature DB >> 8014925

The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients.

F Wolfe1, K Ross, D J Hawley, F K Roberts, M A Cathey.   

Abstract

OBJECTIVE: To determine the prognosis of undifferentiated polyarthritis syndrome in the clinic compared with rheumatoid arthritis (RA).
METHODS: We identified consecutive patients seen within the first 2 years of disease (and further subset into 6-month groups) diagnosed as having either RA or undifferentiated polyarthritis syndrome at the first clinic visit. Undifferentiated polyarthritis syndrome was characterized by clinical presentation, laboratory data, and American College of Rheumatology (ACR) 1958 and 1987 RA criteria. Followup evaluations were done to determine change in diagnosis, resolution of symptoms, and clinical remission of RA.
RESULTS: Undifferentiated polyarthritis syndrome was more common in the clinic than RA (638 vs 503). Of patients with RA 7.6% were symptom free an average of 6.9 years after the first clinic visit. For those with disease onset between 0-6 months and 0-2 years, complete resolution of undifferentiated polyarthritis syndrome occurred in 57.9 and 53.9% of cases, including 46.1 and 35.6% meeting ACR 1987 criteria for RA. Latex positivity was the strongest predictor of failure to resolve subsequently (25.0 and 29.2% resolution) and the best predictor of development of RA (41.7 and 43.1%).
CONCLUSIONS: Nonrheumatoid undifferentiated polyarthritis syndrome is more common in the clinic than RA. Undifferentiated polyarthritis syndrome resolves in more than half the cases, while RA remits in 7.6%. Finally, resolution of RA criteria positive undifferentiated polyarthritis syndrome occurs predominantly in those who are seronegative.

Entities:  

Mesh:

Year:  1993        PMID: 8014925

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  28 in total

1.  Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis.

Authors:  G Hayem; M De Bandt; E Palazzo; S Roux; B Combe; J F Eliaou; J Sany; M F Kahn; O Meyer
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

2.  Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic.

Authors:  J L Hülsemann; H Zeidler
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

3.  Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease.

Authors:  R J Wakefield; M J Green; H Marzo-Ortega; P G Conaghan; W W Gibbon; D McGonagle; S Proudman; P Emery
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

4.  Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.

Authors:  A Stockman; B D Tait; R Wolfe; C A Brand; M J Rowley; M D Varney; R Buchbinder; K D Muirden
Journal:  Rheumatol Int       Date:  2005-09-07       Impact factor: 2.631

5.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  B Combe; R Landewe; C Lukas; H D Bolosiu; F Breedveld; M Dougados; P Emery; G Ferraccioli; J M W Hazes; L Klareskog; K Machold; E Martin-Mola; H Nielsen; A Silman; J Smolen; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

6.  Diagnostic uncertainty and epistemologic humility.

Authors:  Andrew Kelly; Richard S Panush
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

Review 7.  The epidemiology of early inflammatory arthritis.

Authors:  Johanna M W Hazes; Jolanda J Luime
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

8.  Labour force participation among patients with rheumatoid arthritis.

Authors:  A M Chorus; H S Miedema; C J Wevers; S van Der Linden
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

9.  Enhanced MRI in early undifferentiated oligoarthritis of the knee joints: improvements already visible after 2 months of DMARDs treatment.

Authors:  Yasser Emad; Yasser Ragab; Ahmed Shaarawy; Hala Raafat; H A El-Kiki; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2008-06-18       Impact factor: 2.980

10.  Annual incidence of inflammatory joint diseases in a population based study in southern Sweden.

Authors:  M K Söderlin; O Börjesson; H Kautiainen; T Skogh; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.